Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

Autor: Bonner, James A, Harari, Paul M, Giralt, Jordi, Cohen, Roger B, Jones, Christopher U, Sur, Ranjan K, Raben, David, Baselga, Jose, Spencer, Sharon A, Zhu, Junming, Youssoufian, Hagop, Rowinsky, Eric K, Ang, K Kian
Zdroj: In Lancet Oncology 2010 11(1):21-28
Databáze: ScienceDirect